The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease
Open accessAbstract
Genome-wide association studies (GWAS) have identified several risk variants for late-onset Alzheimer's disease (LOAD). These common variants have replicable but small effects on LOAD risk and generally do not have obvious functional effects. Low-frequency coding variants, not detected by GWAS, are predicted to include functional variants with larger effects on risk. To identify low-frequency coding variants with large effects on LOAD risk, we carried out whole-exome sequencing (WES) in 14 large LOAD families and follow-up analyses of the candidate variants in several large LOAD case-control data sets. A rare variant in PLD3 (phospholipase D3; Val232Met) segregated with disease status in two independent families and doubled risk for Alzheimer's disease in seven independent case-control series with a total of more than 11,000 cases and controls of European descent. Gene-based burden analyses in 4,387 cases and controls of European descent and 302 African American cases and controls, with complete sequence data for PLD3, reveal that several variants in this gene increase risk for Alzheimer's disease in both populations. PLD3 is highly expressed in brain regions that are vulnerable to Alzheimer's disease pathology, including hippocampus and cortex, and is expressed at significantly lower levels in neurons from Alzheimer's disease brains compared to control brains. Overexpression of PLD3 leads to a significant decrease in intracellular amyloid-β precursor protein (APP) and extracellular Aβ42 and Aβ40 (the 42- and 40-residue isoforms of the amyloid-β peptide), and knockdown of PLD3 leads to a significant increase in extracellular Aβ42 and Aβ40. Together, our genetic and functional data indicate that carriers of PLD3 coding variants have a twofold increased risk for LOAD and that PLD3 influences APP processing. This study provides an example of how densely affected families may help to identify rare variants with large effects on risk for disease or other complex traits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most of the genes associated with the ~40 loci identified by genome-wide association (GWA) analysis or by rare variant sequencing studies are expressed in glial cells (e.g., APOE, TREM2, BIN1, CD33, INPP5D, CTSB, CTSD, and PICALM).”
From The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques (2019) · cites this paper as Cruchaga et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“gene enrichment analysis indicates that ARMs, but not IRMs, are enriched for known AD risk genes such as Apoe, Trem2, Tyrobp (DAP12), Ctsb, Ctsd, H2-Eb1, and Pld3”
From The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques (2019) · cites this paper as Cruchaga et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“whereas the PLD3 variant, V232M, was identified using a family-based study design [13].”
From Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience (2017) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Recently, several possibly functional, rare variants with large protective [9, 10] and risk effects [11–13] have been identified for AD in APP, APOE, PLD3, and TREM2 using novel study designs.”
From Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience (2017) · cites this paper as [13]
In the citing paper
“We also found that LECs isolated from the meninges of 6-month-old 5xFAD mice showed significant changes in the expression of genes involved in processes such as exocytosis, phospholipase D signaling, and response to low-density lipoprotein (Extended Data Fig. 1f–k), suggesting that meningeal Aβ deposition might affect meningeal LECs early on through deleterious processes previously implicated in”
From Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy (2021) · cites this paper as [14]
In the citing paper
“For example, rare variants in SORL1 and ABCA7 have been identified in family-based studies of LOAD [147–150], each of which have been associated with alterations in APP processing.”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationA General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684
Cleveland, D. W., Fischer, S. G., Kirschner, M. W., & Laemmli, U. K. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75212-0 · Cited by 5,556
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationMeta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Self-citation
Flagged first, then by citations
1 of the 52 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Benitez, B. A. & Cruchaga, C. TREM2 and neurodegenerative disease. N. Engl. J. Med. 369, 1567–1568 (2013)
Cited by
Sorted by citations
Items 101–200 of 463
PLD3 in non-familial Alzheimer's disease
Heilmann‐Heimbach, S., Drichel, D., Clarimón, J., Fernández, M. V., Lacour, A., Wagner, H., Thelen, M., Hernández, I., Fortea, J., Alegret, M., et al. (2015) · Nature · doi:10.1038/nature14039 · Cited by 67
Self-citationTranscriptional signatures of tau and amyloid neuropathology
Castanho, I., Murray, T. K., Hannon, E., Jeffries, A., Walker, E., Laing, E., Baulf, H., Harvey, J., Bradshaw, L., Randall, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.063 · Cited by 62
PLD3 gene variants and Alzheimer's disease
Hooli, B. V., Lill, C. M., Mullin, K., Qiao, D., Lange, C., Bertram, L., & Tanzi, R. E. (2015) · Nature · doi:10.1038/nature14040 · Cited by 64
Nackenoff, A. G., Hohman, T. J., Neuner, S. M., Akers, C. S., Weitzel, N. C., Shostak, A., Ferguson, S. M., Mobley, B., Bennett, D. A., Schneider, J. A., et al. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009406 · Cited by 59
Böhm, C., Chen, F., Sévalle, J., Qamar, S., Dodd, R. B., Li, Y., Schmitt‐Ulms, G., Fraser, P. E., & George‐Hyslop, P. S. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.02.016 · Cited by 66
Oguin, T. H., Sharma, S., Stuart, A. D., Duan, S., Scott, S. A., Jones, C. K., Daniels, J. S., Lindsley, C. W., Thomas, P. G., & Brown, H. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.558817 · Cited by 63
Review: High-performance computing to detect epistasis in genome scale data sets
Upton, A., Trelles, O., Cornejo-García, J. A., & Perkins, J. R. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv058 · Cited by 66
Cleavage of DNA and RNA by PLD3 and PLD4 limits autoinflammatory triggering by multiple sensors
Gavin, A. L., Huang, D., Blane, T. R., Thinnes, T. C., Murakami, Y., Fukui, R., Miyake, K., & Nemazee, D. A. (2021) · Nature Communications · doi:10.1038/s41467-021-26150-w · Cited by 63
Early-Onset Alzheimer Disease and Candidate Risk Genes Involved in Endolysosomal Transport
Kunkle, B. W., Vardarajan, B. N., Naj, A. C., Whitehead, P. L., Rolati, S., Slifer, S., Carney, R. M., Cuccaro, M. L., Vance, J. M., Gilbert, J. R., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1518 · Cited by 58
RAB10: an Alzheimer’s disease resilience locus and potential drug target
Tavana, J., Rosene, M., Jensen, N., Ridge, P. G., Kauwe, J. S. K., & Karch, C. M. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s159148 · Cited by 62
Self-citationAlzheimer's brains show inter-related changes in RNA and lipid metabolism
Barbash, S., Garfinkel, B. P., Maoz, R., Simchovitz, A., Nadorp, B., Guffanti, A., Bennett, E. R., Nadeau, C., Türk, A., Paul, L., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.06.008 · Cited by 62
Ali, M., Timsina, J., Western, D., Liu, M., Beric, A., Budde, J., Do, A., Heo, G., Wang, L., Gentsch, J., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.02.014 · Cited by 61
Self-citationPhospholipase D and Its Essential Role in Cancer.
Cho, J. H., & Han, J. (2017) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2017.0241 · Cited by 60
The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia
Tasaki, S., Gaiteri, C., Mostafavi, S., Jager, P. L. D., & Bennett, D. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00699 · Cited by 61
PLD3 and sporadic Alzheimer's disease risk
Lambert, J., Grenier‐Boley, B., Bellenguez, C., Pasquier, F., Campion, D., Dartigues, J., Berr, C., Tzourio, C., & Amouyel, P. (2015) · Nature · doi:10.1038/nature14036 · Cited by 63
Genetics of Alzheimer’s disease: From pathogenesis to clinical usage
Shao, W., Peng, D., & Wang, X. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.06.074 · Cited by 64
Self-citationBeta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties
Tatarnikova, O. G., Орлов, М. А., & Bobkova, N. V. (2015) · Biochemistry (Moscow) · doi:10.1134/s000629791513012x · Cited by 62
Assessment of the Genetic Architecture of Alzheimer’s Disease Risk in Rate of Memory Decline
Del-Aguila, J. L., Fernández, M. V., Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170834 · Cited by 60
Self-citationRare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease
Jakobsdóttir, J., van der Lee, S. J., Bis, J. C., Chouraki, V. A., Li‐Kroeger, D., Yamamoto, S., Grove, M. L., Naj, A. C., Vronskaya, M., Salazar, J. L., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006327 · Cited by 58
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
Ridge, P. G., & Kauwe, J. S. K. (2018) · Current Genetic Medicine Reports · doi:10.1007/s40142-018-0132-2 · Cited by 58
Self-citationRegulation of Membrane Turnover by Phosphatidic Acid: Cellular Functions and Disease Implications
Thakur, R., Naik, A., Panda, A., & Raghu, P. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00083 · Cited by 58
The Dominantly Inherited Alzheimer Network (DIAN), Li, Z., Del-Aguila, J. L., Dube, U., Budde, J., Martinez, R., Black, K., Xiao, Q., Cairns, N. J., Dougherty, J. D., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0551-4 · Cited by 56
Self-citationCastranio, E. L., Mounier, A., Wolfe, C. M., Nam, K. N., Fitz, N. F., Letronne, F., Schug, J., Koldamova, R. P., & Lefterov, I. M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.006 · Cited by 56
Genetics of Alzheimer’s Disease: the Importance of Polygenic and Epistatic Components
Raghavan, N. S., & Tosto, G. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0787-1 · Cited by 57
Mishra, A., Chauhan, G., Violleau, M., Vojinović, D., Jian, X., Bis, J. C., Li, S., Saba, Y., Grenier‐Boley, B., Yang, Q., et al. (2019) · Brain · doi:10.1093/brain/awz024 · Cited by 60
Bérouti, M., Lammens, K., Heiß, M., Hansbauer, L., Bauernfried, S., Stöckl, J. B., Pinci, F., Piseddu, I., Greulich, W., Wang, M., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.010 · Cited by 57
PLD3 variants in population studies
van der Lee, S. J., Holstege, H. H., Wong, T. H., Jakobsdóttir, J., Bis, J. C., Chouraki, V. A., van Rooij, J., Grove, M. L., Smith, A. V., Amin, N., et al. (2015) · Nature · doi:10.1038/nature14038 · Cited by 55
A rare missense variant of CASP7 is associated with familial late‐onset Alzheimer's disease
Zhang, X., Zhu, C., Beecham, G. W., Vardarajan, B. N., Ma, Y., Lancour, D., Farrell, J. J., Chung, J., Alzheimer's Disease Sequencing Project, Mayeux, R. P., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.10.005 · Cited by 50
PLD3 gene and processing of APP
Fazzari, P., Horre, K., Arranz, A. M., Frigerio, C. S., Saito, T., Saido, T. C., & De Strooper, B. (2017) · Nature · doi:10.1038/nature21030 · Cited by 54
Lin, E., Tsai, S.-J., Kuo, P.-H., Liu, Y.-L., Yang, A. C., & Kao, C.-F. (2017) · Oncotarget · doi:10.18632/oncotarget.15269 · Cited by 54
More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk
Rosenthal, S. L., Bamne, M. N., Wang, X., Berman, S., Snitz, B. E., Klunk, W. E., Sweet, R. A., Demirci, F. Y., López, O. L., & Kamboh, M. I. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.012 · Cited by 54
Self-citationSatoh, J.-I., Yamamoto, Y., Asahina, N., Kitano, S., & Kino, Y. (2014) · Disease Markers · doi:10.1155/2014/123165 · Cited by 53
Unconventional Trafficking of Mammalian Phospholipase D3 to Lysosomes
Gonzalez, A. C., Schweizer, M., Jagdmann, S., Bernreuther, C., Reinheckel, T., Säftig, P., & Daμμe, M. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.100 · Cited by 53
Breusegem, S. Y., & Seaman, M. N. J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.053 · Cited by 51
Huang, T., Ji, Y., Hu, D., Chen, B., Zhang, H., Li, C., Chen, G., Luο, X., Zheng, X., & Lin, X. (2016) · Oncotarget · doi:10.18632/oncotarget.13167 · Cited by 51
From Common to Rare Variants: The Genetic Component of Alzheimer Disease
Nicolas, G., Charbonnier, C., & Campion, D. (2016) · Human Heredity · doi:10.1159/000452256 · Cited by 50
PLD3 is accumulated on neuritic plaques in Alzheimer’s disease brains
Satoh, J., Kino, Y., Yamamoto, Y., Kawana, N., Ishida, T., Saito, Y., & Arima, K. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0070-5 · Cited by 50
Santa, P., Garreau, A., Serpas, L., Ferrière, A., Blanco, P., Soni, C., & Sisirak, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629922 · Cited by 56
Li, J., Zou, L., Zhou, Y., Li, L., Zhu, Y., Yang, Y., Gong, Y., Lou, J., Ke, J., Zhang, Y., et al. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22637 · Cited by 49
Ma, J., Liu, M., Wang, Y., Xin, C., Zhang, H., Chen, S., Zheng, X., Zhang, X., Xiao, F.-L., & Yang, S. (2020) · Aging · doi:10.18632/aging.103461 · Cited by 49
Impact of late-onset Alzheimer’s genetic risk factors on beta-amyloid endocytic production
Almeida, C. G., Mirfakhar, F. S., Perdigão, C., & Burrinha, T. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2825-9 · Cited by 53
An intermediate-effect size variant in UMOD confers risk for chronic kidney disease
Olinger, E. G., Schaeffer, C., Kidd, K. O., Elhassan, E. A. E., Cheng, Y., Dufour, I., Schiano, G., Mabillard, H. R., Pasqualetto, E., Hofmann, P., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114734119 · Cited by 48
El-Shater, R. E., Awad, A. W., Abdel-Khalek, E. K., El-Bahnasawy, H. H., Meaz, T. M., & Okba, E. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-41214-1 · Cited by 51
Parallel Discovery of Alzheimer’s Therapeutics
Lo, A. W., Ho, C., Cummings, J., & Kosik, K. S. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008228 · Cited by 50
Alzheimer's disease genes and autophagy
Yoon, S.-Y., & Kim, D.-H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.018 · Cited by 42
Impaired brain development and reduced cognitive function in phospholipase D-deficient mice
Burkhardt, U. E., Stegner, D., Hattingen, E., Beyer, S., Nieswandt, B., & Klein, J. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.04.052 · Cited by 47
Genetic Biomarkers on Age-Related Cognitive Decline
Lin, C., Lin, E., & Lane, H. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00247 · Cited by 50
Phospholipase D and Choline Metabolism
Onono, F. O., & Morris, A. J. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_320 · Cited by 47
From beta amyloid to altered proteostasis in Alzheimer’s disease
Bruni, A. C., Bernardi, L., & Gabelli, C. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101126 · Cited by 47
Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
Leko, M. B., Štrac, D. Š., Mück‐Šeler, D., Pivac, N., Stanić, G., Hof, P. R., & Šimić, G. (2014) · Croatian Medical Journal · doi:10.3325/cmj.2014.55.347 · Cited by 48
Alzheimer’s genes in microglia: a risk worth investigating
Sudwarts, A., & Thinakaran, G. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00679-4 · Cited by 52
Yu, J., Crouch, J. M., Jamal, S. M., Bamshad, M. J., & Tabor, H. K. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36610 · Cited by 45
Alzheimer’s Disease: From Genetic Variants to the Distinct Pathological Mechanisms
Sun, Q., Xie, N., Tang, B., Li, R., & Shen, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00319 · Cited by 46
Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44
AlzBase: An Integrative Database for Gene Dysregulation in Alzheimer’s Disease
Bai, Z., Han, G., Xie, B., Wang, J., Song, F., Peng, X., & Lei, H. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9011-3 · Cited by 44
Nucleic Acid Sensing by Toll-Like Receptors in the Endosomal Compartment
Miyake, K., Shibata, T., Fukui, R., Sato, R., Saitoh, S.-I., & Murakami, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941931 · Cited by 46
Initiative, A. D. N., Nho, K. T., Kim, S., Horgusluoglu, E., Risacher, S. L., Shen, L., Kim, D., Lee, S., Foroud, T., Shaw, L. M. J., et al. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0267-0 · Cited by 44
Alzheimer's disease and other dementias: advances in 2014
Bateman, R. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70301-1 · Cited by 43
He, L., Loika, Y., Park, Y., Bennett, D. A., Kellis, M., Kulminski, A. M., & Initiative, A. D. N. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01263-4 · Cited by 41
The impact of rare genetic variants on Alzheimer disease
Deyn, L. D., & Sleegers, K. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01062-1 · Cited by 46
The microglial lysosomal system in Alzheimer’s disease: Guardian against proteinopathy
Van Acker, Z. P., Perdok, A., Bretou, M., & Annaert, W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101444 · Cited by 45
Alzheimer’s disease: rare variants with large effect sizes
Del-Aguila, J. L., Koboldt, D. C., Black, K., Chasse, R., Norton, J., Wilson, R. K., & Cruchaga, C. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.07.008 · Cited by 41
Huang, Y., Liang, L., Moffatt, M. F., Cookson, W., & Lin, X. (2015) · Genetic Epidemiology · doi:10.1002/gepi.21905 · Cited by 39
Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
Ando, K., Houben, S., Homa, M., de Fisenne, M.-A., Potier, M., Erneux, C., Brion, J., & Leroy, K. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.583755 · Cited by 42
Challenge accepted: uncovering the role of rare genetic variants in Alzheimer’s disease
Khani, M., Gibbons, E., Bras, J., & Guerreiro, R. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00505-9 · Cited by 39
Self-citationZhang, D., Fan, Y., Wang, D., Bi, R., Zhang, C., Fang, Y., & Yao, Y. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9353-5 · Cited by 41
Herber, J., Njavro, J. R., Feederle, R., Schepers, U., Müller, U., Bräse, S., Müller, S. A., & Lichtenthaler, S. F. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000608 · Cited by 40
Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts
Swerdlow, R. H., Hui, D., Chalise, P., Sharma, P., Wang, X., Andrews, S. J., Pa, J., Mahnken, J. D., Morris, J. K., Wilkins, H., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12119 · Cited by 39
Self-citationMembrane lipid raft homeostasis is directly linked to neurodegeneration
Moll, T., Marshall, J. N. G., Soni, N., Zhang, S., Cooper‐Knock, J., & Shaw, P. J. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210026 · Cited by 37
Key Disease Mechanisms Linked to Alzheimer’s Disease in the Entorhinal Cortex
Bottero, V., Powers, D., Yalamanchi, A., Quinn, J. P., & Potashkin, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083915 · Cited by 35
Fernández, M. V., Liu, M., Beric, A., Johnson, M., Cetin, A., Patel, M. R., Budde, J., Kohlfeld, P., Bergmann, K., Lowery, J., et al. (2024) · Scientific Data · doi:10.1038/s41597-024-03485-9 · Cited by 41
Self-citationOlive, C., Ibanez, L., Farias, F. H. G., Wang, F., Budde, J. P., Norton, J. B., Gentsch, J., Morris, J. C., Li, Z., Dube, U., et al. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-200019 · Cited by 32
Self-citationRare and de novo coding variants in chromodomain genes in Chiari I malformation
Sadler, B. E., Wilborn, J., Antunes, L., Kuensting, T., Hale, A. T., Gannon, S. R., McCall, K., Cruchaga, C., Harms, M. B., Voisin, N., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.12.001 · Cited by 37
Self-citationRole of the endolysosomal pathway and exosome release in tau propagation
Yan, M., & Zheng, T. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104988 · Cited by 36
Yu, M., Risacher, S. L., Nho, K. T., Wen, Q., Oblak, A. L., Unverzagt, F. W., Apostolova, L. G., Farlow, M. R., Brosch, J. R., Clark, D. G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113691 · Cited by 36
Towards Personalized Intervention for Alzheimer’s Disease
Peng, X., Xing, P., Li, X., Qian, Y., Song, F., Bai, Z., Han, G., & Lei, H. (2016) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.01.006 · Cited by 34
Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease
Fernández, M. V., Kim, J. H., Budde, J., Black, K., Medvedeva, A., Saef, B. A., Deming, Y. K., Del‐Aguila, J. L., Ibáñez, L., Dube, U., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007045 · Cited by 35
Self-citationSMPD3 deficiency perturbs neuronal proteostasis and causes progressive cognitive impairment
Stoffel, W., Jenke, B., Schmidt‐Soltau, I., Binczek, E., Brodesser, S., & Hammels, I. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0560-7 · Cited by 33
Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2018) · BioMed Research International · doi:10.1155/2018/1483791 · Cited by 36
New Insights into the Molecular Bases of Familial Alzheimer’s Disease
D’Argenio, V., & Sarnataro, D. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020026 · Cited by 35
Additional mechanisms conferring genetic susceptibility to Alzheimer’s disease
Calero, M., Gómez‐Ramos, A., Calero, O., Soriano, E., Ávila, J., & Medina, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00138 · Cited by 38
Wang, J., Yu, J., & Tan, L. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8779-5 · Cited by 33
Identification of rare variants in Alzheimer’s disease
Lord, J., Lu, A. J., & Cruchaga, C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00369 · Cited by 36
Self-citationWang, B., Bao, S., Zhang, Z., Zhou, X., Wang, J., Fan, Y., Zhang, Y., Li, Y., Chen, L., Jia, Y., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.006 · Cited by 32
Self-citationGSAP regulates lipid homeostasis and mitochondrial function associated with Alzheimer’s disease
Xu, P., Chang, J. C., Zhou, X., Wang, W., Bamkole, M. A., Wong, E., Bettayeb, K., Jiang, L.-L., Huang, T. Y., Luo, W., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202446 · Cited by 36
Rare and low-frequency variants in human common diseases and other complex traits
Lettre, G. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102437 · Cited by 36
Genetic Analyses of Alzheimer’s Disease in China: Achievements and Perspectives
Zhang, D., Xu, M., Bi, R., & Yao, Y. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00435 · Cited by 32
Ischemic Stroke: From Next Generation Sequencing and GWAS to Community Genomics?
Black, M. L., Wang, W., & Wang, W. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0083 · Cited by 31
Mitsunaga, S., Hosomichi, K., Okudaira, Y., Nakaoka, H., Suzuki, Y., Kuwana, M., Sato, S., Kaneko, Y., Homma, Y., Oka, A., et al. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.50 · Cited by 33
A nonsense mutation in PRNP associated with clinical Alzheimer's disease
Guerreiro, R. J., Brás, J., Wojtas, A., Rademakers, R., Hardy, J., & Graff-Radford, N. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.013 · Cited by 32
Self-citationGenetics of Alzheimer’s Disease in the African American Population
Logue, M. W., Dasgupta, S., & Farrer, L. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165189 · Cited by 29
Bridging the Gap between Statistical and Biological Epistasis in Alzheimer’s Disease
Ebbert, M., Ridge, P. G., & Kauwe, J. S. K. (2015) · BioMed Research International · doi:10.1155/2015/870123 · Cited by 30
Self-citationXiang, Q., Bi, R., Xu, M., Zhang, D., Tan, L., Zhang, C., Fang, Y., & Yao, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0065-2 · Cited by 31
Motegi, T., Kochi, Y., Matsuda, K., Kubo, M., Yamamoto, K., & Momozawa, Y. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215062 · Cited by 28
Whole-Exome Sequencing Analysis of Alzheimer’s Disease in Non-APOE*4 Carriers
Fan, K.-H., Feingold, E., Rosenthal, S. L., Demirci, F. Y., Ganguli, M., López, O. L., & Kamboh, M. I. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200037 · Cited by 27
Self-citationPierouli, K., Papakonstantinou, E., Papageorgiou, L., Diakou, I., Mitsis, Τ., Dragoumani, K., Spandidos, D. A., Bacopoulou, F., Chrousos, G. P., Goulielmos, G. N., et al. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5208 · Cited by 29
PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease
Blanco‐Luquin, I., Altuna, M., de Gordoa, J. S., Urdánoz‐Casado, A., Roldán, M., Cámara, M. S., Zelaya, M. V., Erro, M. E., Echávarri, C., & Mendióroz, M. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0547-3 · Cited by 30
Fernández, M. V., Budde, J., Del‐Aguila, J. L., Ibáñez, L., Deming, Y. K., Harari, O., Norton, J. B., Morris, J. C., Goate, A., NIA-LOAD family study group, et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00209 · Cited by 30
Self-citationGuix, F. X. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24526 · Cited by 30
Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer’s disease
Yokoyama, J. S., Bonham, L. W., Sears, R. L., Klein, E., Karydas, A., Kramer, J. H., Miller, B. L., & Coppola, G. (2015) · BMC Neurology · doi:10.1186/s12883-015-0304-6 · Cited by 28
Metadata
- Authors
- Cruchaga, C., Karch, C. M., Jin, S. C., Benitez, B. A., Cai, Y., Guerreiro, R., Harari, O., Norton, J., Budde, J., Bertelsen, S., Jeng, A. T., Cooper, B., Skorupa, T., Carrell, D., Levitch, D., Hsu, S., Choi, J., Ryten, M., UK Brain Expression Consortium (UKBEC), Hardy, J., Ryten, M., Trabzuni, D., Weale, M. E., Ramasamy, A., Smith, C., Sassi, C., Bras, J., Gibbs, J. R., Hernandez, D. G., Lupton, M. K., Powell, J., Forabosco, P., Ridge, P. G., Corcoran, C. D., Tschanz, J. T., Norton, M. C., Munger, R. G., Schmutz, C., Leary, M., Demirci, F. Y., Bamne, M. N., Wang, X., Lopez, O. L., Ganguli, M., Medway, C., Turton, J., Lord, J., Braae, A., Barber, I., Brown, K., The Alzheimer’s Research UK (ARUK) Consortium, Passmore, P., Craig, D., Johnston, J., McGuinness, B., Todd, S., Heun, R., Kölsch, H., Kehoe, P. G., Hooper, N. M., Vardy, E. R. L. C., Mann, D. M., Pickering-Brown, S., Brown, K., Kalsheker, N., Lowe, J., Morgan, K., David Smith, A., Wilcock, G., Warden, D., Holmes, C., Pastor, P., Lorenzo-Betancor, O., Brkanac, Z., Scott, E., Topol, E., Morgan, K., Rogaeva, E., Singleton, A. B., Hardy, J., Kamboh, M. I., St George-Hyslop, P., Cairns, N., Morris, J. C., Kauwe, J. S. K., & Goate, A. M.
- Affiliations
- Washington University in St. Louis (US)
- National Institutes of Health (US)
- National Hospital for Neurology and Neurosurgery (GB)
- King's College London (GB)
- University of Edinburgh (GB)
- National Research Council (IT)
- Brigham Young University (US)
- Utah State University (US)
- University of Pittsburgh (US)
- University of Nottingham (GB)
- Queen's University Belfast (GB)
- Royal Derby Hospital (GB)
- University of Bonn (DE)
- University of Bristol (GB)
- University of Leeds (GB)
- Newcastle University (GB)
- University of Manchester (GB)
- University of Oxford (GB)
- University of Washington (US)
- Scripps Research Institute (US)
- University of Toronto (CA)
- Corresponding author
- Cruchaga, Carlos
- ORCID
- Cruchaga, Carlos
- Karch, Celeste M.
- Jin, Sheng Chih
- Guerreiro, Rita
- Harari, Oscar
- Budde, John
- Bertelsen, Sarah
- Skorupa, Tara
- Carrell, David
- Hsu, Simon
- Trabzuni, Daniah
- Weale, Michael E.
- Ramasamy, Adaikalavan
- Smith, Colin
- Sassi, Celeste
- Gibbs, J. Raphael
- Hernandez, Dena G.
- Lupton, Michelle K.
- Powell, John
- Forabosco, Paola
- Ridge, Perry G.
- Tschanz, JoAnn T.
- Norton, Maria C.
- Munger, Ronald G.
- Demirci, F. Yesim
- Wang, Xingbin
- Ganguli, Mary
- Turton, James
- Lord, Jenny
- Braae, Anne
- Passmore, Peter
- Craig, David
- McGuinness, Bernadette
- Todd, Stephen
- Heun, Reinhard
- Kehoe, Patrick G.
- Hooper, Nigel M.
- Vardy, Emma R.L.C.
- Mann, David M.
- Pickering-Brown, Stuart
- Kalsheker, Noor
- Lowe, James
- Wilcock, Gordon
- Holmes, Clive
- Scott, Erick
- Topol, Eric
- Rogaeva, Ekaterina
- Singleton, Andrew B.
- Kamboh, M. Ilyas
- Cairns, Nigel
- Morris, John C.
- Goate, Alison M.
- Venue
- Nature
- Published
- 2013-12-11
- Volume
- 505
- Issue
- 7484
- Pages
- 550-554
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4050701
- OpenAlex
- W2099248872
- Cited by
- 461
- References
- 52
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 23 · 2023: 21 · 2022: 22 · 2021: 32 · 2020: 30 · 2019: 37 · 2018: 50 · 2017: 44 · 2016: 50 · 2015: 68 · 2014: 51
- FWCI
- 39.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- U.S. Department of Health and Human Services
- Pfizer
- BrightFocus Foundation
- Wellcome Trust (100140, 089703, 081864, 089698)
- National Institute for Health and Care Research (ACF-2007-18-011, ACF-2012-17-017)
- National Institutes of Health (5p30ns069329-02)
- Genentech
- U.S. Public Health Service (NIH R01039700)
- Canadian Institutes of Health Research
- Medical Research Council (MR/K01417X/1, MC_G1000735, MR/L016400/1, MC_G1000734)
- National Institute on Aging (R01 AG 11380, R01AG039700, NIH P50AG05681, RF1AG044546, ZIAAG000950, R01AG042611, AG 07562, R01AG041718, AG-005133, P50AG005133, K01AG046374, AG041718, R01AG007562, R01AG030653, ZO1 AG000950-10, R01AG011380, R01AG035083, U24 AG21886, AG023652, R01AG021136, R01AG018712, R01AG041797, R01AG044546, R01 AG18712, ZO1AG000950-11, Z01AG000950, P50AG005681, P01 AG0 3991, P01AG003991, U24AG026395, R01 AG 21136, U24AG056270, P01AG026276, U24AG021886, AG 030653)
- National Institute on Drug Abuse (R25DA027995)
- National Institute of Neurological Disorders and Stroke (P30-NS069329)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- late-onset Alzheimer's disease, PLD3, rare coding variants, amyloid-beta processing, amyloid precursor protein, gene burden analysis, familial Alzheimer's disease, African Americans, European ancestry, therapeutic target, genetic risk variants
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Black or African American, Brain, Europe, Exodeoxyribonucleases, Female, Humans, Male, Peptide Fragments, Phospholipase D, Protein Processing, Post-Translational, Genetic Variation, Case-Control Studies, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Age of Onset, Genetic Predisposition to Disease, Exome, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
